Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Metoprolol
Drug ID BADD_D01445
Description Metoprolol is a selective beta-1 blocker commonly employed as the succinate and tartrate derivatives depending if the formulation is designed to be of immediate release or extended release.[A175159, L5530] The possibility of the generation of these formulations comes from the lower systemic bioavailability of the succinate derivative.[T274] To this date, it is one of the preferred beta-blockers in general clinical guidelines and it is widely prescribed in the Netherlands, New Zealand, and the US.[A175162] Metoprolol was developed since 1969 by US Pharmaceutical Holdings I and FDA approved in 1978.[L5527]
Indications and Usage Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension.[A175141] Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm.[A175141] All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.[L5533]
Marketing Status approved; investigational
ATC Code C07AB02
DrugBank ID DB00264
KEGG ID D02358
MeSH ID D008790
PubChem ID 4171
TTD Drug ID D0I2MK
NDC Product Code 70518-3506; 46708-292; 62207-970; 62332-113; 46708-290; 0615-8422; 0615-8423; 46708-291; 62332-114; 62332-112; 71205-003; 0615-8421; 65977-0117
UNII GEB06NHM23
Synonyms Metoprolol | Toprol | Betaloc | Betaloc-Astra | Betaloc Astra | Betalok | CGP-2175 | CGP 2175 | CGP2175 | H 93-26 | H 93 26 | H 9326 | Metoprolol Tartrate | Seloken | Spesicor | Spesikor | Metoprolol Succinate | Metoprolol CR-XL | Metoprolol CR XL | Toprol-XL | Toprol XL | Beloc-Duriles | Beloc Duriles | Lopressor
Chemical Information
Molecular Formula C15H25NO3
CAS Registry Number 51384-51-1
SMILES CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Purpura non-thrombocytopenic01.01.04.006--Not Available
Injection site nodule23.07.04.009; 12.07.03.034; 08.02.03.0340.000023%Not Available
Toxic skin eruption12.03.01.073; 23.03.05.003; 10.01.01.0080.000017%Not Available
Ocular icterus09.01.01.007; 06.08.03.009; 01.06.04.0070.000017%Not Available
Pulseless electrical activity02.03.04.0200.000057%Not Available
Dysplasia08.03.04.0070.000007%Not Available
Dermatitis psoriasiform23.03.14.004--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Angiopathy24.03.02.007--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Hot flush21.02.02.001; 08.01.03.027; 24.03.01.005--
Breast disorder21.05.04.004--Not Available
Cardiac disorder02.11.01.0030.000063%Not Available
Connective tissue disorder10.04.04.026; 15.06.01.006--Not Available
Libido disorder19.08.03.004; 21.03.02.006--Not Available
Malnutrition14.03.02.0040.000007%Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Temperature regulation disorder08.05.01.004; 05.03.04.0130.000013%Not Available
Erectile dysfunction21.03.01.007; 19.08.04.0010.000048%
Inner ear disorder04.04.02.002--Not Available
Adverse drug reaction08.06.01.0090.000139%Not Available
Disease recurrence08.01.03.0500.000115%Not Available
Drug intolerance08.06.01.0130.000135%Not Available
Obstructive airways disorder22.03.01.011--Not Available
Psychotic disorder19.03.01.0020.000037%
Pulmonary toxicity22.01.02.007; 12.03.01.0130.000017%Not Available
Hepatobiliary disease09.01.08.003--Not Available
Hyperlipidaemia14.08.03.0010.000017%
Poor quality sleep17.15.04.002; 19.02.05.0050.000018%Not Available
The 14th Page    First    Pre   14 15 16 17    Next   Last    Total 17 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene